St. Jude Medical to Present at the Barclays Capital 2012 Global Healthcare Conference
March 05 2012 - 4:15PM
Business Wire
St. Jude Medical, Inc. (NYSE:STJ) will present at the Barclays
Capital 2012 Global Healthcare Conference on Tuesday, March 13, in
Miami. John Heinmiller, executive vice president and chief
financial officer, will address the conference at 9:00 a.m. EDT.
The presentation will also be webcast live at www.sjm.com.
About St. Jude Medical
St. Jude Medical, Inc. develops medical technology and services
that focus on putting more control into the hands of those who
treat cardiac, neurological and chronic pain patients worldwide.
The company is dedicated to advancing the practice of medicine by
reducing risk wherever possible and contributing to successful
outcomes for every patient. St. Jude Medical is headquartered in
St. Paul, Minn. and has four major focus areas that include cardiac
rhythm management, atrial fibrillation, cardiovascular and
neuromodulation. For more information, please visit
www.sjm.com.
Forward-Looking Statements
This news release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
that involve risks and uncertainties. Such forward-looking
statements include the expectations, plans and prospects for the
Company, including potential clinical successes, anticipated
regulatory approvals and future product launches, and projected
revenues, margins, earnings and market shares. The statements made
by the Company are based upon management’s current expectations and
are subject to certain risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. These risks and uncertainties include
market conditions and other factors beyond the Company’s control
and the risk factors and other cautionary statements described in
the Company’s filings with the SEC, including those described in
the Risk Factors and Cautionary Statements sections of the
Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2011. The Company does not intend to update these
statements and undertakes no duty to any person to provide any such
update under any circumstance.
SJM (NYSE:STJ)
Historical Stock Chart
From May 2024 to Jun 2024
SJM (NYSE:STJ)
Historical Stock Chart
From Jun 2023 to Jun 2024